Figure 5 from: Padilla-Sanchez V (2020) In silico analysis of SARS-CoV-2 spike glycoprotein and insights into antibody binding. Research Ideas and Outcomes 6: e55281. https://doi.org/10.3897/rio.6.e55281

Figure 5 Docking interface between the modified m396 antibody and SARS-CoV-2 spike protein RBD. In magenta is m396 mutant and in cyan SARS-CoV-2 RBD. These five mutations introduce many electrostatic interactions between the partners therefore stabilizing very much the binding.